251 related articles for article (PubMed ID: 24290398)
1. Magnesium sulfate for cerebral palsy prevention.
Rouse DJ; Gibbins KJ
Semin Perinatol; 2013 Dec; 37(6):414-6. PubMed ID: 24290398
[TBL] [Abstract][Full Text] [Related]
2. Intrapartum magnesium for prevention of cerebral palsy: continuing controversy?
Cahill AG; Stout MJ; Caughey AB
Curr Opin Obstet Gynecol; 2010 Apr; 22(2):122-7. PubMed ID: 20179596
[TBL] [Abstract][Full Text] [Related]
3. Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Bachnas MA; Mose JC; Effendi JS; Andonotopo W
J Perinat Med; 2014 Jan; 42(1):129-34. PubMed ID: 24062546
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulfate for the prevention of cerebral palsy.
Rouse DJ
Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114
[TBL] [Abstract][Full Text] [Related]
5. Does antenatal magnesium sulfate prevent cerebral palsy in preterm infants? The final trial?
Huusom LD; Brok J; Hegaard HK; Pryds O; Secher NJ
Acta Obstet Gynecol Scand; 2012 Nov; 91(11):1346-7. PubMed ID: 23016563
[No Abstract] [Full Text] [Related]
6. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants.
Costantine MM; Drever N
Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805
[TBL] [Abstract][Full Text] [Related]
7. Antenatal magnesium sulfate and neuroprotection.
Doyle LW
Curr Opin Pediatr; 2012 Apr; 24(2):154-9. PubMed ID: 22227787
[TBL] [Abstract][Full Text] [Related]
8. [Gynecology/Obstetrics. Magnesium sulfate for fetal neuroprotection in preterm delivery. Latest advances in contraception.].
Irion O; Julen O; Dubuisson JB; Yaron M; Lourenço AG
Rev Med Suisse; 2011 Jan; 7(278):117-20. PubMed ID: 21400942
[TBL] [Abstract][Full Text] [Related]
9. The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
Mittendorf R; Roizen NJ; Pryde PG
J Perinatol; 2004 Jul; 24(7):465-6. PubMed ID: 15224123
[No Abstract] [Full Text] [Related]
10. The role of magnesium sulfate in the prevention of cerebral palsy.
Scheans P
Neonatal Netw; 2012; 31(2):121-4. PubMed ID: 22397798
[TBL] [Abstract][Full Text] [Related]
11. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Crowther CA; Hiller JE; Doyle LW; Haslam RR;
JAMA; 2003 Nov; 290(20):2669-76. PubMed ID: 14645308
[TBL] [Abstract][Full Text] [Related]
12. In defense of magnesium sulfate.
Elliott JP; Lewis DF; Morrison JC; Garite TJ
Obstet Gynecol; 2009 Jun; 113(6):1341-1348. PubMed ID: 19461432
[TBL] [Abstract][Full Text] [Related]
13. Antenatal magnesium sulphate.
Peebles DM; Marlow N; Brocklehurst P
BMJ; 2010 Nov; 341():c6004. PubMed ID: 21097982
[No Abstract] [Full Text] [Related]
14. Antenatal magnesium sulfate for neuroprotection before preterm birth?
Stanley FJ; Crowther C
N Engl J Med; 2008 Aug; 359(9):962-4. PubMed ID: 18753653
[No Abstract] [Full Text] [Related]
15. Brain lesions in newborns exposed to high-dose magnesium sulfate during preterm labor.
Mittendorf R; Dammann O; Lee KS
J Perinatol; 2006 Jan; 26(1):57-63. PubMed ID: 16319938
[TBL] [Abstract][Full Text] [Related]
16. Maternal obesity and neuroprotective magnesium sulfate.
McPherson J; Smiley S; Stamilio D
Am J Obstet Gynecol; 2015 Oct; 213(4):582.e1-6. PubMed ID: 26116874
[TBL] [Abstract][Full Text] [Related]
17. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants--but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis.
Huusom LD; Secher NJ; Pryds O; Whitfield K; Gluud C; Brok J
BJOG; 2011 Jan; 118(1):1-5. PubMed ID: 21197681
[No Abstract] [Full Text] [Related]
18. Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Kamyar M; Manuck TA; Stoddard GJ; Varner MW; Clark E
BJOG; 2016 Jun; 123(7):1161-6. PubMed ID: 26036660
[TBL] [Abstract][Full Text] [Related]
19. [Prevention of cerebral palsy using magnesium sulfate in pre-term newborns].
Marret S; Chollat C; Levèque C; Marpeau L
Arch Pediatr; 2011 Mar; 18(3):324-30. PubMed ID: 21257296
[TBL] [Abstract][Full Text] [Related]
20. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
Horton AL; Lai Y; Rouse DJ; Spong CY; Leveno KJ; Varner MW; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; O'Sullivan MJ; Hankins GD; Caritis SN;
Am J Perinatol; 2015 Mar; 32(4):387-92. PubMed ID: 25241107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]